ArticlePloS one2025
Spatiotemporal prediction of obesity rates and model interpretability analysis from a public health perspective.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study, focusing on the assessment of obesity prevalence trends in public health management, proposes an improved Transformer model that integrates temporal embeddings with spatially-constrained feature dependencies rather than purely geographic adjacency. Using state-level data from the CDC BRFSS, the method first performs joint temporal-health encoding (JTH) of obesity prevalence time series and health indicators. It then incorporates temporal decay and a learnable spatial constraint matrix (STA) into the attention mechanism, while employing dual-branch consistency training to enhance stability and generalization. We conducted comparative and ablation experiments on ten states, including Alaska and Alabama, and carried out independent validation on unseen states such as Guam and Idaho. The results show that the proposed approach outperforms representative models including MLP, LSTM, 1D-CNN, Mamba, iTransformer, and TimeMixer across metrics such as MAE, RMSE, sMAPE, R2, and MASE. Ablation experiments further demonstrate that JTH and STA contribute complementary improvements to model performance, while independent validation confirmed that the R2 values for all states exceeded 0.84. In addition, SHAP analysis was employed to illustrate the contributions and dependencies of key features, providing interpretable evidence to support, thereby guiding evidence-based resource allocation in obesity prevention and control.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.